Viatris Inc at Evercore ISI Healthcare Conference Transcript
Okay. Thank you, guys, for being here. Super excited to have Viatris management join us. I think the last time we had you guys, Rajiv used to be irregular, and he would always fly in, and we would just go freestyle on so many different ANDAs with him, but excited to speak to you. And I feel like when Rajiv would come down every time, there were so many ends that were so interesting, but I feel like this time around, I think it's much more the strategy and broader conversation on where the story is heading, both from the base business and financials.
So Scott, I'll let you kick things off perhaps.
Sure. So when I think about Viatris, I think it's not one business, right? It's for three separate businesses. It's a global generics footprint, which was a Mylan company. These established products, some of the most iconic brands in the world, the Lipitors, Norvasc, Xanax, Viagra, Celebrex, that came through the Upjohn acquisition, and then there's a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

